Literature DB >> 2827590

Comparison of the immune response to Epstein-Barr virus and cytomegalovirus in sera and synovial fluids of patients with rheumatoid arthritis.

M Musiani1, M Zerbini, S Ferri, M Plazzi, G Gentilomi, M La Placa.   

Abstract

The immune response against two herpesviruses has been determined in sera and matched synovial fluids of patients with rheumatoid arthritis (RA) and compared with that of a healthy control population. The increased level of antibody to Epstein-Barr virus (EBV) induced antigens in patients with RA resembles the antibody pattern observed against cytomegalovirus (CMV) induced antigens, which suggests the presence of a pathological condition in patients with RA that can reactivate latent viral infections. The antibody response against EBV and CMV observed in synovial fluids excludes the local production of specific antibodies against EBV and CMV antigens.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2827590      PMCID： PMC1003402          DOI： 10.1136/ard.46.11.837

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  24 in total

1.  Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Demonstration by precipitation and immunofluorescence.

Authors:  M A Aslpaugh; E M Tan
Journal:  Arthritis Rheum       Date:  1976 Jul-Aug

2.  DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

3.  Antibodies against cytomegalovirus-induced early antigens (CMV-EA) in immunosuppressed renal-allograft recipients.

Authors:  T H The; H K Andersen; E S Spencer; G Klein
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

4.  Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr virus infection.

Authors:  M A Catalano; D A Carson; J C Niederman; P Feorino; J H Vaughan
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

5.  Epstein-Barr virus antibodies in multiple sclerosis.

Authors:  C V Sumaya; L W Myers; G W Ellison
Journal:  Arch Neurol       Date:  1980-02

6.  Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis.

Authors:  M A Alspaugh; G Henle; E T Lennette; W Henle
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

7.  Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis.

Authors:  P B Ferrell; C T Aitcheson; G R Pearson; E M Tan
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

8.  Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line.

Authors:  Y Hinuma; M Konn; J Yamaguchi; D J Wudarski; J R Blakeslee; J T Grace
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

9.  Immunologic identification of Epstein-Barr virus early antigen in a P3HR-1 cell extract.

Authors:  R W Veltri; W H Wainwright; P M Sprinkle
Journal:  J Natl Cancer Inst       Date:  1976-08       Impact factor: 13.506

10.  Antibodies to Epstein-Barr virus-specific antigens in patients with hairy-cell leukemia.

Authors:  K Sakamoto; M Aiba; I Katayama; J L Sullivan; R E Humphreys; D T Purtilo
Journal:  Int J Cancer       Date:  1981       Impact factor: 7.396
View more
  10 in total

1.  Impairment of cytomegalovirus and host balance in elderly subjects.

Authors:  M Musiani; M Zerbini; D Zauli; G Cometti; M La Placa
Journal:  J Clin Pathol       Date:  1988-07       Impact factor: 3.411

2.  Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment.

Authors:  Mattias Magnusson; Mikael Brisslert; Kiandoht Zendjanchi; Magnus Lindh; Maria I Bokarewa
Journal:  Rheumatology (Oxford)       Date:  2010-06-14       Impact factor: 7.580

3.  Antibody reactivity to an Epstein-Barr virus BERF4-encoded epitope occurring also in Asp-57 region of HLA-DQ8 beta chain. Childhood Diabetes in Finland Study Group.

Authors:  P Parkkonen; H Hyöty; J Ilonen; H Reijonen; S Ylä-Herttuala; P Leinikki
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

4.  Correlative studies of rheumatoid factors and anti-viral antibodies in patients with rheumatoid arthritis.

Authors:  A S Ferraro; M M Newkirk
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

5.  Yersinia-specific antibodies in serum and synovial fluid in patients with Yersinia triggered reactive arthritis.

Authors:  O Mäki-Ikola; R Lahesmaa; J Heesemann; R Merilahti-Palo; R Saario; A Toivanen; K Granfors
Journal:  Ann Rheum Dis       Date:  1994-08       Impact factor: 19.103

Review 6.  Human Cytomegalovirus and Autoimmune Diseases: Where Are We?

Authors:  Francesca Gugliesi; Selina Pasquero; Gloria Griffante; Sara Scutera; Camilla Albano; Sergio Fernando Castillo Pacheco; Giuseppe Riva; Valentina Dell'Oste; Matteo Biolatti
Journal:  Viruses       Date:  2021-02-08       Impact factor: 5.048

Review 7.  Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation.

Authors:  Andreas Lossius; Jorunn N Johansen; Øivind Torkildsen; Frode Vartdal; Trygve Holmøy
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

Review 8.  Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis.

Authors:  Robert J Ball; Alison Avenell; Lorna Aucott; Peter Hanlon; Mark A Vickers
Journal:  Arthritis Res Ther       Date:  2015-09-29       Impact factor: 5.156

9.  Modulation of pro-inflammatory activation of monocytes and dendritic cells by aza-bis-phosphonate dendrimer as an experimental therapeutic agent.

Authors:  Yannick Degboé; Séverine Fruchon; Michel Baron; Delphine Nigon; Cédric Olivier Turrin; Anne-Marie Caminade; Rémy Poupot; Alain Cantagrel; Jean-Luc Davignon
Journal:  Arthritis Res Ther       Date:  2014-04-18       Impact factor: 5.156

10.  Detection of cytomegalovirus and Epstein-Barr virus in labial salivary glands in Sjogren's syndrome and non-specific sialadenitis.

Authors:  N Maitland; S Flint; C Scully; S J Crean
Journal:  J Oral Pathol Med       Date:  1995-08       Impact factor: 4.253
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.